Aller au contenu

24th Congress of EHA

13 Juin 2019 · 4 joursAmsterdam, NetherlandsHematologyEnglish
Congrès de HematologySite officiel ↗← Tout l'agenda
24th Congress of EHA
Amsterdam

Programme overview

Typical day · provisional programme

  1. 09:00

    Opening plenary: state of the art in hematology

    Auditorium A
  2. 11:00

    Free communications & discussed posters

    Room 2
  3. 14:00

    Symposium: new guidelines and clinical cases

    Auditorium B
  4. 16:30

    Round table: innovation, data and everyday practice

    Room 2

MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.

Vidéos de ce congrès

Pierre Fenaux · Imetelstat provides durable transfusion independence in heavily transfused
Play the video · Pierre Fenaux · Imetelstat provides durable transfusion independence in heavily transfusedInscription gratuite requise pour lancer la lecture

Pierre Fenaux · 00:09:35

Myeloma highlights from EHA 2019
Play the video · Myeloma highlights from EHA 2019Inscription gratuite requise pour lancer la lecture

00:05:35

Philippe Moreau · D-VTd in induction prior to and consolidation after ASCT improves PFS
Play the video · Philippe Moreau · D-VTd in induction prior to and consolidation after ASCT improves PFSInscription gratuite requise pour lancer la lecture

Philippe Moreau · 00:05:39

Mohamad Mohty · CAR T Cells for treating acute leukaemia
Play the video · Mohamad Mohty · CAR T Cells for treating acute leukaemiaInscription gratuite requise pour lancer la lecture

Mohamad Mohty · 00:03:02

Kirsten Fischer · Venetoclax plus obinutuzumab improves PFS and MRD-negativity
Play the video · Kirsten Fischer · Venetoclax plus obinutuzumab improves PFS and MRD-negativityInscription gratuite requise pour lancer la lecture

Kirsten Fischer · 00:10:44

Christopher Hourigan · Intervention for AML patients with MRD can result in improved survival
Play the video · Christopher Hourigan · Intervention for AML patients with MRD can result in improved survivalInscription gratuite requise pour lancer la lecture

Christopher Hourigan · 00:10:37

Etienne De Braekeleer · Inhibition of NADK strongly inhibits T-ALL cells from growing
Play the video · Etienne De Braekeleer · Inhibition of NADK strongly inhibits T-ALL cells from growingInscription gratuite requise pour lancer la lecture

Etienne De Braekeleer · 00:06:48

Mark Roschewski · Novel immunotherapy 5F9+rituximab well tolerated with rapid and durable responses
Play the video · Mark Roschewski · Novel immunotherapy 5F9+rituximab well tolerated with rapid and durable responsesInscription gratuite requise pour lancer la lecture

Mark Roschewski · 00:12:34

Mohamad Mohty · Multiple myeloma science from EHA 2019
Play the video · Mohamad Mohty · Multiple myeloma science from EHA 2019Inscription gratuite requise pour lancer la lecture

Mohamad Mohty · 00:04:40

Anton Hagenbeek · Comment on fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities
Play the video · Anton Hagenbeek · Comment on fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbiditiesInscription gratuite requise pour lancer la lecture

Anton Hagenbeek · 00:01:25

Anton Hagenbeek · Comment on pregnancy outcomes in patients with chronic myeloid leukaemia
Play the video · Anton Hagenbeek · Comment on pregnancy outcomes in patients with chronic myeloid leukaemiaInscription gratuite requise pour lancer la lecture

Anton Hagenbeek · 00:01:41

Mark Roschewski · Safety and efficacy of escalating doses of the hu5f9-g4 with rituximab in patients
Play the video · Mark Roschewski · Safety and efficacy of escalating doses of the hu5f9-g4 with rituximab in patientsInscription gratuite requise pour lancer la lecture

Mark Roschewski · 00:05:26